Pulse lineResearch With Heart Logo

ARIC Publications

Filters: First Letter Of Last Name is A  [Clear All Filters]
Journal Article
Kraja AT, Vaidya D, Pankow JS, et al. "A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium." Diabetes. 2011;60(4):1329-39.
Kraja AT, Vaidya D, Pankow JS, et al. "A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium." Diabetes. 2011;60(4):1329-39.
Arnett DK, Rautaharju P, Crow R, et al. "Black-white differences in electrocardiographic left ventricular mass and its association with blood pressure (the ARIC study). Atherosclerosis Risk in Communities." Am J Cardiol. 1994;74(3):247-52.
Colicino E, Marioni R, Ward-Caviness C, et al. "Blood DNA methylation sites predict death risk in a longitudinal study of 12, 300 individuals." Aging (Albany NY). 2020;12(14):14092-14124.
Colicino E, Marioni R, Ward-Caviness C, et al. "Blood DNA methylation sites predict death risk in a longitudinal study of 12, 300 individuals." Aging (Albany NY). 2020;12(14):14092-14124.
Agha G, Mendelson MM, Ward-Caviness CK, et al. "Blood Leukocyte DNA Methylation Predicts Risk of Future Myocardial Infarction and Coronary Heart Disease." Circulation. 2019;140(8):645-657.
Agha G, Mendelson MM, Ward-Caviness CK, et al. "Blood Leukocyte DNA Methylation Predicts Risk of Future Myocardial Infarction and Coronary Heart Disease." Circulation. 2019;140(8):645-657.
Agha G, Mendelson MM, Ward-Caviness CK, et al. "Blood Leukocyte DNA Methylation Predicts Risk of Future Myocardial Infarction and Coronary Heart Disease." Circulation. 2019;140(8):645-657.
Norby FL, Agarwal SK, Maclehose RF, et al. "Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study." Circ Arrhythm Electrophysiol. 2012;5(1):155-62.
Norby FL, Agarwal SK, Maclehose RF, et al. "Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study." Circ Arrhythm Electrophysiol. 2012;5(1):155-62.
Luoto R, Sharrett AR, Schreiner P, Sorlie PD, Arnett D, Ephross S. "Blood pressure and menopausal transition: the Atherosclerosis Risk in Communities study (1987-95)." J Hypertens. 2000;18(1):27-33.
Hsu CC, Brancati FL, Astor BC, et al. "Blood pressure, atherosclerosis, and albuminuria in 10,113 participants in the atherosclerosis risk in communities study." J Hypertens. 2009;27(2):397-409.
Tamariz LJ, Young HJ, Pankow JS, et al. "Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study." Am J Epidemiol. 2008;168(10):1153-60.
Khalid U, Wruck LMiller, Quibrera PMiguel, et al. "BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study." Int J Cardiol. 2017;233:61-66.
Fox E, Taylor H, Andrew M, et al. "Body mass index and blood pressure influences on left ventricular mass and geometry in African Americans: The Atherosclerotic Risk In Communities (ARIC) Study." Hypertension. 2004;44(1):55-60.
Bancks MP, Alonso A, Gottesman RF, Mosley TH, Selvin E. "Brain function and structure and risk for incident diabetes: The Atherosclerosis Risk in Communities Study." Alzheimers Dement. 2017;13(12):1345-1354.
Sinner MF, Stepas KA, Moser CB, et al. "B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies." Europace. 2014;16(10):1426-33.
Sinner MF, Stepas KA, Moser CB, et al. "B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies." Europace. 2014;16(10):1426-33.
Sinner MF, Stepas KA, Moser CB, et al. "B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies." Europace. 2014;16(10):1426-33.
Sinner MF, Stepas KA, Moser CB, et al. "B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies." Europace. 2014;16(10):1426-33.
Sinner MF, Stepas KA, Moser CB, et al. "B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies." Europace. 2014;16(10):1426-33.
Matsushita K, Sang Y, Ballew SH, et al. "Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study." Arterioscler Thromb Vasc Biol. 2014;34(8):1770-7.
Agarwal SK, Norby FL, Whitsel EA, et al. "Cardiac Autonomic Dysfunction and Incidence of Atrial Fibrillation: Results From 20 Years Follow-Up." J Am Coll Cardiol. 2017;69(3):291-299.
Agarwal SK, Norby FL, Whitsel EA, et al. "Cardiac Autonomic Dysfunction and Incidence of Atrial Fibrillation: Results From 20 Years Follow-Up." J Am Coll Cardiol. 2017;69(3):291-299.
Skali H, Shah A, Gupta DK, et al. "Cardiac structure and function across the glycemic spectrum in elderly men and women free of prevalent heart disease: the Atherosclerosis Risk In the Community study." Circ Heart Fail. 2015;8(3):448-54.
Saunders JT, Nambi V, de Lemos JA, et al. "Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study." Circulation. 2011;123(13):1367-76.
Dadu RT, Fornage M, Virani SS, et al. "Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study." Stroke. 2013;44(7):1803-8.
Lee C D, Folsom AR, Pankow JS, Brancati FL. "Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction." Circulation. 2004;109(7):855-60.
Knopman DS, Mosley TH, Catellier DJ, A Sharrett R. "Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort." Neurology. 2005;65(6):876-81.
Knopman D, Boland LL, Mosley T, et al. "Cardiovascular risk factors and cognitive decline in middle-aged adults." Neurology. 2001;56(1):42-8.
Gregson J, Kaptoge S, Bolton T, et al. "Cardiovascular Risk Factors Associated With Venous Thromboembolism." JAMA Cardiol. 2019;4(2):163-173.
Gregson J, Kaptoge S, Bolton T, et al. "Cardiovascular Risk Factors Associated With Venous Thromboembolism." JAMA Cardiol. 2019;4(2):163-173.
Gregson J, Kaptoge S, Bolton T, et al. "Cardiovascular Risk Factors Associated With Venous Thromboembolism." JAMA Cardiol. 2019;4(2):163-173.
Gregson J, Kaptoge S, Bolton T, et al. "Cardiovascular Risk Factors Associated With Venous Thromboembolism." JAMA Cardiol. 2019;4(2):163-173.
Bekwelem W, Jensen PN, Norby FL, et al. "Carotid Atherosclerosis and Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities Study." Stroke. 2016;47(6):1643-6.
Bekwelem W, Jensen PN, Norby FL, et al. "Carotid Atherosclerosis and Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities Study." Stroke. 2016;47(6):1643-6.
Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. "Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study." Am J Epidemiol. 1991;134(3):250-6.
Chen LYee, Leening MJG, Norby FL, et al. "Carotid Intima-Media Thickness and Arterial Stiffness and the Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study, Multi-Ethnic Study of Atherosclerosis (MESA), and the Rotterdam Study." J Am Heart Assoc. 2016;5(5).
Suzuki T, Wang W, Wilsdon A, et al. "Carotid Intima-Media Thickness and the Risk of Sudden Cardiac Death: The ARIC Study and the CHS." J Am Heart Assoc. 2020;9(19):e016981.
Wuttke M, Li Y, Li M, et al. "A catalog of genetic loci associated with kidney function from analyses of a million individuals." Nat Genet. 2019;51(6):957-972.
Wuttke M, Li Y, Li M, et al. "A catalog of genetic loci associated with kidney function from analyses of a million individuals." Nat Genet. 2019;51(6):957-972.
Wuttke M, Li Y, Li M, et al. "A catalog of genetic loci associated with kidney function from analyses of a million individuals." Nat Genet. 2019;51(6):957-972.
Wuttke M, Li Y, Li M, et al. "A catalog of genetic loci associated with kidney function from analyses of a million individuals." Nat Genet. 2019;51(6):957-972.
Wuttke M, Li Y, Li M, et al. "A catalog of genetic loci associated with kidney function from analyses of a million individuals." Nat Genet. 2019;51(6):957-972.
Wuttke M, Li Y, Li M, et al. "A catalog of genetic loci associated with kidney function from analyses of a million individuals." Nat Genet. 2019;51(6):957-972.
Holmes MV, Lange LA, Palmer T, et al. "Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis." Am J Hum Genet. 2014;94(2):198-208.
Holmes MV, Lange LA, Palmer T, et al. "Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis." Am J Hum Genet. 2014;94(2):198-208.
Guo L, Akahori H, Harari E, et al. "CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis." J Clin Invest. 2018;128(3):1106-1124.
Guo L, Akahori H, Harari E, et al. "CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis." J Clin Invest. 2018;128(3):1106-1124.
Sargurupremraj M, Suzuki H, Jian X, et al. "Cerebral small vessel disease genomics and its implications across the lifespan." Nat Commun. 2020;11(1):6285.
Sargurupremraj M, Suzuki H, Jian X, et al. "Cerebral small vessel disease genomics and its implications across the lifespan." Nat Commun. 2020;11(1):6285.
Sargurupremraj M, Suzuki H, Jian X, et al. "Cerebral small vessel disease genomics and its implications across the lifespan." Nat Commun. 2020;11(1):6285.
Sargurupremraj M, Suzuki H, Jian X, et al. "Cerebral small vessel disease genomics and its implications across the lifespan." Nat Commun. 2020;11(1):6285.
Sargurupremraj M, Suzuki H, Jian X, et al. "Cerebral small vessel disease genomics and its implications across the lifespan." Nat Commun. 2020;11(1):6285.
Wong T Y, Klein R, A Sharrett R, et al. "Cerebral white matter lesions, retinopathy, and incident clinical stroke." JAMA. 2002;288(1):67-74.
Coresh JJ, Heerspink HJL, Sang Y, et al. "Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies." Lancet Diabetes Endocrinol. 2019;7(2):115-127.
Matsushita K, Selvin E, Bash LD, Franceschini N, Astor BC, Coresh J. "Change in estimated GFR associates with coronary heart disease and mortality." J Am Soc Nephrol. 2009;20(12):2617-24.
Cobb LK, McAdams-Demarco MA, Gudzune KA, et al. "Changes in Body Mass Index and Obesity Risk in Married Couples Over 25 Years: The ARIC Cohort Study." Am J Epidemiol. 2016;183(5):435-43.
Foti K, Matsushita K, Koton S, et al. "Changes in hypertension control in a community-based population of older adults, 2011-2013 to 2016-2017." Am J Hypertens. 2020.
Patel MD, Kalbaugh CA, Chang PP, et al. "Characteristics and outcomes of patients with acute decompensated heart failure developing after hospital admission." Am J Cardiol. 2014;114(10):1530-6.
Natarajan P, Pampana A, Graham SE, et al. "Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices." Nat Commun. 2021;12(1):2182.
Natarajan P, Pampana A, Graham SE, et al. "Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices." Nat Commun. 2021;12(1):2182.
Natarajan P, Pampana A, Graham SE, et al. "Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices." Nat Commun. 2021;12(1):2182.
Natarajan P, Pampana A, Graham SE, et al. "Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices." Nat Commun. 2021;12(1):2182.
Natarajan P, Pampana A, Graham SE, et al. "Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices." Nat Commun. 2021;12(1):2182.
Natarajan P, Pampana A, Graham SE, et al. "Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices." Nat Commun. 2021;12(1):2182.
Natarajan P, Pampana A, Graham SE, et al. "Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices." Nat Commun. 2021;12(1):2182.
Folsom AR, Lutsey PL, Astor BC, Wattanakit K, Heckbert SR, Cushman M. "Chronic kidney disease and venous thromboembolism: a prospective study." Nephrol Dial Transplant. 2010;25(10):3296-301.
Folsom AR, Lutsey PL, Astor BC, Wattanakit K, Heckbert SR, Cushman M. "Chronic kidney disease and venous thromboembolism: a prospective study." Nephrol Dial Transplant. 2010;25(10):3296-301.
Alonso A, Lopez FL, Matsushita K, et al. "Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study." Circulation. 2011;123(25):2946-53.
Alonso A, Lopez FL, Matsushita K, et al. "Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study." Circulation. 2011;123(25):2946-53.
Alonso A, Lopez FL, Matsushita K, et al. "Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study." Circulation. 2011;123(25):2946-53.
Lamprea-Montealegre JA, Sharrett ARichey, Matsushita K, Selvin E, Szklo M. "Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: the ARIC study." Atherosclerosis. 2014;234(1):42-6.
Sanders AE, Sofer T, Wong Q, et al. "Chronic Periodontitis Genome-wide Association Study in the Hispanic Community Health Study / Study of Latinos." J Dent Res. 2017;96(1):64-72.
Ding N, Sang Y, Chen J, et al. "Cigarette Smoking, Smoking Cessation, and Long-Term Risk of 3 Major Atherosclerotic Diseases." J Am Coll Cardiol. 2019;74(4):498-507.
Folsom AR, Yao L, Alonso A, et al. "Circulating Biomarkers and Abdominal Aortic Aneurysm Incidence: The Atherosclerosis Risk in Communities (ARIC) Study." Circulation. 2015;132(7):578-85.
de Larriva APArenas, Norby FL, Chen LYee, et al. "Circulating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study." Int J Cardiol. 2017;241:223-228.
de Larriva APArenas, Alonso A, Norby FL, Roetker NS. "Circulating ceruloplasmin, ceruloplasmin-associated genes and the incidence of venous thromboembolism in the Atherosclerosis Risk in Communities study." J Thromb Haemost. 2019;17(5):818-826.
de Larriva APArenas, Norby FL, Chen LYee, et al. "Circulating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study." Int J Cardiol. 2017;241:223-228.
Alonso A, Rooney MR, Chen LYee, et al. "Circulating electrolytes and the prevalence of atrial fibrillation and supraventricular ectopy: The Atherosclerosis Risk in Communities (ARIC) study." Nutr Metab Cardiovasc Dis. 2020;30(7):1121-1129.

Pages